Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ALTIRIS INCListing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | Award | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | Award | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | Award | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | Award | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | Award | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | Award | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | Award | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | Award | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | $75.5K | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | $79.9K | SEC | ||
ANTARES PHARMA, INC.Listing unverified | AwardD (derivative) | $221.3K | SEC |